Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa

Fig. 2

Proportion of serotypable lytA-positive samples (n = 607) by lytA cycle threshold value (Ct-value) among patients hospitalized with severe acute respiratory illness at Chris Hani-Baragwanath Academic Hospital, Soweto, South Africa, 2009–2012. Serotypable samples were samples tested with the serotyping assay from which a serotype/serogroup included in the assay was detected

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us